A case of complete resection of prostate stromal sarcoma after neoadjuvant chemotherapy

INTRODUCTION: Prostatic stromal sarcoma is an extremely rare malignancy of the prostate with a poor prognosis. CASE PRESENTATION: A 65‐year‐old man presented with dyschezia, and computed tomography showed a large prostate mass. The diagnosis was prostate stromal sarcoma by transrectal needle biopsy....

Descripción completa

Detalles Bibliográficos
Autores principales: Hodotsuka, Naoto, Suzuki, Yasutomo, Suzuki, Kyota, Honda, Yuichiro, Endo, Shuma, Kuribayashi, Eigo, Obayashi, Kotaro, Minowa, Tadaaki, Hatori, Tsutomu, Kondo, Yukihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315243/
https://www.ncbi.nlm.nih.gov/pubmed/37405039
http://dx.doi.org/10.1002/iju5.12596
Descripción
Sumario:INTRODUCTION: Prostatic stromal sarcoma is an extremely rare malignancy of the prostate with a poor prognosis. CASE PRESENTATION: A 65‐year‐old man presented with dyschezia, and computed tomography showed a large prostate mass. The diagnosis was prostate stromal sarcoma by transrectal needle biopsy. Magnetic resonance imaging suggested rectal infiltration. The patient underwent 4 courses of neoadjuvant chemotherapy with gemcitabine and docetaxel hydrate followed by total pelvic exenteration. CONCLUSION: No recurrence has occurred at 5 years after the surgery. This is the first report of complete resection in prostate stromal sarcoma after neoadjuvant chemotherapy with gemcitabine and docetaxel hydrate.

Ejemplares similares